Quarter Period Consolidated Statement Of Comprehensive Income

Oncolys BioPharma Inc. - Filing #7342826

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,148,938,000 JPY
-1,148,938,000 JPY
-1,148,938,000 JPY
-1,148,938,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.